Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
International Journal of Hematology|June 14, 2014
Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statementBor-Sheng Ko, Cheng-Shyong Chang, Ming-Chih Chang, et al.
Ebiomedicine|January 22, 2019
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patientsCheng-Hong Tsai, Chi-Yuan Yao, Feng-Min Tien, et al.
Blood|March 2, 2013
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaChieh-Lung Cheng, Hsin-An Hou, Ming-Cheng Lee, et al.
Blood Advances|May 17, 2021
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLCheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, et al.
Blood|October 8, 2009
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterationsJih-Luh Tang, Hsin-An Hou, Chien-Yuan Chen, et al.
Blood|August 31, 2012
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolutionShang-Ju Wu, Yuan-Yeh Kuo, Hsin-An Hou, et al.
Plos One|June 11, 2015
High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in TaiwanJih-Luh Tang, Hsiang-Chi Kung, Weng-Chi Lei, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
Bone Marrow Transplantation|May 16, 2019
Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015Minako Iida, Yoshihisa Kodera, Anthony Dodds, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell TransplantationJohan Maertens, Aaron C Logan, Junho Jang, et al.
Pageof 12